Article
Pharmacokinetic interactions between tacrolimus and Wuzhi capsule in liver transplant recipients: Genetic polymorphisms affect the drug interaction.
Chemico-biological interactions - 1 Mar 2024
Huang Siqi, Song Wei, Jiang Shuangmiao, Li Yuanchen, Wang Min, Yang Na, Zhu Huaijun
Abstract excerpt
Wuzhi capsule (WZC), a commonly used Chinese patent medicine to treat various types of liver dysfunction in China, increases the exposure of tacrolimus (TAC) in liver transplant recipients. However, this interaction has inter-individual variability, and the underlying mechanism remains unclear. Current research indicates that CYP3A4/5 and drug transporters influence the disposal of both drugs. This study aims to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
